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Engagement of neutrophils by E-selectin results
in integrin activation. Here, we investigated pri-
marymouseneutrophils inwhole bloodbyusing
intravital microscopy and autoperfused flow
chambers. Slow rolling on E-selectin coimmobi-
lized with intercellular adhesion molecule-1
(ICAM-1) required P-selectin glycoprotein li-
gand (PSGL)-1, was dependent on aLb2 integrin
(LFA-1), and required continuous E-selectin en-
gagement. Slow rolling was abolished by phar-
macological blockade of spleen tyrosine kinase
(Syk) and was absent in Syk/ bone-marrow
chimeric mice. Treatment with tumor necrosis
factor-a lowered rolling velocity further and
induced CXC chemokine ligand-1 (CXCL1) and
CXC chemokine receptor-2 (CXCR2)-depen-
dent leukocyte arrest on E-selectin and ICAM-
1. Arrest but not rolling was blocked by an allo-
steric inhibitor of LFA-1 activation. Neutrophil
recruitment in a thioglycollate-induced perito-
nitis model was almost completely inhibited in
Selplg/ mice or Syk/ bone-marrow chi-
meras treated with pertussis toxin. This iden-
tifies a second neutrophil-activation pathway
that is as important as activation through G pro-
tein-coupled receptors (GPCRs).
INTRODUCTION
E-selectin is expressed on inflamed endothelial cells and
engages P-selectin glycoprotein ligand (PSGL)-1 (Xia
et al., 2002), CD44 (Katayama et al., 2005), macrophage
antigen (Mac)-1 (aMb2) (Crutchfield et al., 2000), and other
ligands. E-selectin is known to mediate slow leukocyte
rolling in vivo (Kunkel and Ley, 1996). Slow rolling requires
the presence and function of b2-integrins (Jung et al.,
1998). Rolling of isolated human neutrophils on E-selectininduces p38 MAPK-dependent adhesion to inflamed en-
dothelial cells or cells transfected with E-selectin and
intercellular adhesion molecule (ICAM)-1 (Simon et al.,
2000). However, when neutrophils are rolled over immobi-
lized E-selectin and ICAM-1 in their physiological whole-
blood environment, rolling is greatly enhanced compared
to immobilized E-selectin alone, but no firm adhesion is
seen (Chesnutt et al., 2006).
Neutrophils can also activate their b2-integrins and
arrest in response to immobilized chemokines (Rainger
et al., 1997). The most relevant chemokine receptor re-
sponsible for arrest of mouse neutrophils under conditions
of inflammation in vivo was recently identified as CXC che-
mokine receptor-2 (CXCR2) (Smith et al., 2004a). In recon-
stituted systems, immobilized chemokines are sufficient
to trigger arrest of model leukocytes within less than one
second (Campbell et al., 1998; Grabovsky et al., 2000).
During inflammation, endothelial cells express both
CXC chemokine ligand-1 (CXCL1, formerly known as
keratinocyte-derived chemokine, KC), an effective arrest
chemokine that activates CXCR2 (Smith et al., 2005), and
E-selectin. The E-selectin-dependent and chemokine-
dependent recruitment pathways are partially redundant,
because blocking either one alone blocks neutrophil
recruitment to the inflamed peritoneal cavity by approxi-
mately 50%, but blocking both almost completely elimi-
nates neutrophil recruitment (Smith et al., 2004a). In vivo,
neutrophils integrate signals from chemokine and E-se-
lectin engagement to eventually become adherent (Kunkel
et al., 2000). The E-selectin ligand on neutrophils respon-
sible for integrin activation and subsequent slow rolling is
unknown.
PSGL-1 is a ligand for all selectins and binds L- and P-
selectin through its NH2-terminal sialyl Lewis x (sLe
x)-con-
taining O-glycan and a nearby tyrosine sulfate residue
(McEver, 2002; McEver and Cummings, 1997). E-selectin
binding to PSGL-1 requires sialylated and fucosylated
O-glycans but not tyrosine sulfatation (McEver and Cum-
mings, 1997). PSGL-1-deficient mice show a pronounced
impairment of P-selectin-dependent neutrophil rolling, ad-
hesion, and recruitment, whereas E-selectin-dependent
rolling and adhesion is only mildly impaired (Xia et al.,Immunity 26, 773–783, June 2007 ª2007 Elsevier Inc. 773
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on leukocytes generates signals that are thought to be in-
tegrated with those from other activators (Zimmerman
et al., 1996): the expression of transcription factors, che-
mokines, and cytokines is enhanced when leukocytes
receive simultaneous signals via PSGL-1 and G protein-
coupled receptors (Galt et al., 2001; Lindemann et al.,
2005; Weyrich et al., 1995, 1996). Furthermore, engage-
ment of PSGL-1 induces tyrosine phosphorylation and
activation of MAP kinases in human neutrophils, as well as
activation of b2-integrin binding to ICAM-1 (Hidari et al.,
1997; Simon et al., 2000).
Upon PSGL-1 engagement, the cytoplasmatic tail of
PSGL-1 becomes associated with the spleen tyrosine
kinase (Syk) (Urzainqui et al., 2002). Syk, a nonreceptor
tyrosine kinase found in hematopoietic cells, has two
SH2 domains, which are involved in the binding to the im-
munoreceptor tyrosine-based activation motifs (ITAM) of
the actin-linking proteins moesin and ezrin in the PSGL-1
complex and other surface receptor complexes (Berton
et al., 2005). This leads to recruitment and activation of
Syk with subsequent phosphorylation of intracellular sub-
strates. Downstream signals from PSGL-1 engagement
are incompletely understood (Abbal et al., 2006). Syk is
also involved in integrin outside-in signaling (Mocsai
et al., 2002; Schymeinsky et al., 2006).
Neutrophils express lymphocyte function antigen (LFA)-
1 (aLb2), Mac-1, and small amounts of axb2 (gp 150,95)
(Parkos, 1997). Both LFA-1 and Mac-1 (Dunne et al.,
2002) have been found to contribute to neutrophil adhe-
sion in inflamed microvessels in vivo. LFA-1 undergoes a
series of conformational changes resulting in partial and
full activation (Laudanna, 2005). Allosteric inhibitors of
LFA-1 activation were recently shown to stabilize a par-
tially activated form of LFA-1 (Salas et al., 2004; Shimaoka
et al., 2003a) that supports rolling on ICAM-1 but not firm
adhesion.
The first suggestion that E-selectin engagement may
activate b2-integrins came from observations that neutro-
phils that adhered to TNF-a-stimulated human umbilical
vein endothelial cells (HUVECs) showed increased rosett-
ing with C3bi-coated erythrocytes, reflecting activated
Mac-1 (Lo et al., 1991). This Mac-1 activation was com-
pletely prevented when E-selectin was blocked (Lo et al.,
1991). The relevance of E-selectin binding for integrin acti-
vation was confirmed in a flow-chamber assay with Ficoll-
isolated human blood neutrophils on L-cells transfected
with E-selectin alone or with ICAM-1 (Simon et al., 2000).
Ficoll-isolated neutrophils undergo a number of pheno-
typic changes during and after the isolation process (For-
syth and Levinsky, 1990; Glasser and Fiederlein, 1990;
Kuijpers et al., 1991) and cannot maintain rolling at high
wall shear stress levels similar to those in vivo.
We reasoned that it would be worthwhile to revisit E-se-
lectin signaling by using neutrophils in their native whole
blood, without any isolation procedure that might alter
their activation status and rolling ability. To this end, we
employed a recently developed autoperfused flow cham-
ber (Chesnutt et al., 2006; Smith et al., 2004b, 2006),774 Immunity 26, 773–783, June 2007 ª2007 Elsevier Inc.which allows direct visualization of neutrophil interactions
with a molecularly defined substrate. Because E-selectin
is not as efficient as P-selectin at inducing leukocyte cap-
ture (Smith et al., 2004b), we increased the E-selectin con-
centration, which resulted in lower rolling velocities than
typically seen in vivo, where both E- and P-selectin are
expressed. To confirm the physiological relevance of the
findings made in the autoperfused flow chamber, we stud-
ied neutrophil rolling and adhesion by intravital micros-
copy and neutrophil recruitment in a thioglycollate-
induced model of peritonitis. Our results identify a second
neutrophil-activation pathway that is as important as acti-
vation through G protein-coupled receptors.
RESULTS
PSGL Engagement Triggers Slow Rolling
Because neutrophils are extremely sensitive to isolation
procedures, all experiments were conducted in whole
blood in vivo or in an autoperfused flow chamber at
5.94 dyn/cm2 (Chesnutt et al., 2006; Smith et al., 2006).
Some flow chambers were perfused with blood for 6 min,
fixed, and stained for myeloperoxidase to identify neutro-
phils (data not shown). The rolling velocity of WT neutro-
phils was 2.2 mm/s on E-selectin and decreased to
1.0 mm/s on E-selectin and ICAM-1 (Figure 1A). To test
the role of CD44 and PSGL-1 in E-selectin-dependent
slow rolling, Cd44/ or Selplg/ mice were cannulated
and connected to autoperfused flow chambers. Selplg/
neutrophils in whole blood showed a slightly higher rolling
velocity on E-selectin compared to WT neutrophils and
a drastically elevated rolling velocity on E-selectin and
ICAM-1 that was identical to the rolling velocity on E-se-
lectin alone (Figure 1B). By contrast, Cd44/ neutrophils
rolled almost normally (Figure 1A). These results show that
PSGL-1 on neutrophils is required for slowing down rolling
neutrophils upon E-selectin engagement.
To examine which b2-integrin is responsible for slow roll-
ing on E-selectin and ICAM-1, we measured the rolling
velocity of neutrophils of untreated mice before and after
blocking of CD11a (LFA-1) and/or CD11b (Mac-1). In the
autoperfused flow chamber, blocking CD11b had no effect
on the rolling velocity compared to the control (Figure 1C).
However, the inhibition of CD11a (LFA-1) led to an increase
of rolling velocity to a level similar to that seen in the ab-
sence of ICAM-1, which was not further increased by
blocking of both LFA-1 and Mac-1 (Figure 1C). Adding
ICAM-1 to P-selectin-coated flow chambers also reduced
rolling velocity by a similar amount as on E-selectin (Fig-
ure 1D), which is also largely LFA-1 dependent (data not
shown).
To investigate which b2-integrin is responsible for iso-
lated E-selectin-induced slow rolling in vivo, we used
intravital microscopy of cremaster muscle venules in
P-selectin-deficient mice. 2 hr after TNF-a injection, the
hemodynamic parameters were similar in all groups (Table
1), and average rolling velocity was 3.3 ± 0.7 mm/s (Fig-
ure 1E). Blocking of CD11b did not elevate the rolling ve-
locity, whereas blocking of CD11a or both CD11a and
Immunity
Spleen Tyrosine Kinase Necessary for Slow RollingFigure 1. PSGL-1, but Not CD44, Is Required for Neutrophil Slow Rolling on ICAM-1 upon E-Selectin Engagement
(A–D) Carotid cannulas were placed in untreated mice and connected to E-selectin-coated and E-selectin-coated and ICAM-1-coated autoperfused
flow chambers.
(A) Rolling velocity of neutrophils from WT and Cd44/ mice presented as mean ± SEM.
(B) Rolling velocity of neutrophils from untreated WT and PSGL-1-deficient mice on E-selectin and E-selectin+ICAM presented as mean ± SEM.
(C) Rolling velocity of untreated neutrophils on E-selectin+ICAM-1 before and after blocking LFA-1 or Mac-1 or both.
(D) Rolling velocity of neutrophils from untreated mice on P-selectin or E-selectin with or without ICAM-1.
(E) In vivo analysis of the rolling velocity of neutrophils in inflamed cremaster venules of P-selectin-deficient Selp/ mice 2 hr after TNF-a injection.
(F) Neutrophil adhesion in the flow chamber after coimmobilization of CXCL1 (10 mg/ml) with P-selectin+ICAM-1 or E-selectin and ICAM-1. The wall
shear stress in all flow chamber experiments was 5.94 dynes/cm2. At least three mice and four flow chambers per group.
(G–I) Intravital microscopy of cremaster muscle venules from P-selectin-deficient (Selp/) mice and E-selectin-deficient (Sele/) mice 2 hr after
TNF-a application. Rolling velocity (G), rolling flux fraction (H), and number of adherent cells (I). At least 4 mice and 20 vessels per group.
*p < 0.05; #p < 0.05. Data presented are mean ± SEM.CD11b led to a significant increase (p < 0.05). These data
demonstrate that E-selectin-induced slow rolling is de-
pendent on LFA-1 and not on Mac-1 in vitro and in vivo.
In order to investigate the physiological role of slow roll-
ing on E-selectin and ICAM-1 compared to faster rolling
on P-selectin and ICAM-1 (Figure 1D), we performed
flow-chamber experiments with coimmobilized CXCL1
and measured neutrophil adhesion. CXCL1 at 10 mg/ml in-
duced neutrophil arrest on E-selectin and ICAM-1 but not
on P-selectin and ICAM-1 in flow chambers perfused by
untreated mice (Figure 1F). To confirm these findingsin vivo, we conducted intravital microscopy of the cremas-
ter muscle of P-selectin-deficient mice and E-selectin-de-
ficient mice 2 hr after TNF-a application and measured
rolling velocities (Figure 1G), rolling flux fraction (Fig-
ure 1H), and number of adherent cells (Figure 1I). E-
selectin-deficient mice showed a higher rolling velocity
(Figure 1G), increased rolling flux fraction (Figure 1H),
and reduced number of adherent cells (Figure 1I), com-
pared to P-selectin-deficient mice. These in vivo and
in vitro data show that slower rolling velocities induced
by E-selectin and ICAM-1 support adhesion.Immunity 26, 773–783, June 2007 ª2007 Elsevier Inc. 775
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Antibody Treatment Venules Diameter (mm) Centerline Velocity (mm/s) Wall Shear Rate (1000 s1)
Without Ab 18 28 ± 2 3.2 ± 0.1 2.0 ± 0.2
M1/70 15 27 ± 2 3.1 ± 0.1 2.0 ± 0.1
TIB-217 14 26 ± 2 3.1 ± 0.1 2.0 ± 0.2
M1/70 + TIB-217 16 29 ± 2 3.1 ± 0.1 1.9 ± 0.1
Diameter, centerline velocity, and wall shear rate are presented as mean ± SEM of all investigated venules.Continous E-Selectin Engagement Is Required
to Sustain LFA-1–ICAM-1 Interactions
We previously showed that neutrophils did not roll in auto-
perfused flow chambers coated with ICAM-1 alone (Ches-
nutt et al., 2006; Smith et al., 2006). To determine whether
E-selectin engagement ‘‘switches on’’ b2-integrin activa-
tion or whether continous engagement is required to keep
LFA-1 in an activated conformation, we coated one half of
the chambers with E-selectin and ICAM-1 and the other
half with ICAM-1. The cells rolled on E-selectin and
ICAM-1 and immediately detached when they reached
the ICAM-1-only zone (Figure 2A). Neutrophils rolling on
E-selectin and ICAM-1 for 6 min immediately detached
after injecting a monoclonal E-selectin antibody (9A9) (Fig-
ure 2B). These data show that continuous E-selectin-in-
duced signaling is required to keep LFA-1 in an activated
conformation; there is no apparent ‘‘memory’’ for prior en-
gagement of E-selectin ligands.
Syk Is Required for Integrin Activation after
E-Selectin and P-Selectin Binding to PSGL-1
The tyrosine kinase Syk is associated with the cytoplas-
matic tail of PSGL-1 and is also involved in downstream
signaling (Urzainqui et al., 2002). Pretreatment of mice
with piceatannol, an inhibitor of Syk, did not influence
the rolling velocity of neutrophils on E-selectin or P-selec-776 Immunity 26, 773–783, June 2007 ª2007 Elsevier Inc.tin, but the decrease of rolling velocity on E-selectin and
ICAM-1 was almost completely abolished after Syk
blockade (Figure 3A and data not shown). To confirm
our findings, chimeric mice were used that lack Syk
expression in hematopoietic cells. Syk/ neutrophils
showed a similar rolling velocity on E-selectin as WT
neutrophils but failed to reduce their rolling velocity on
E-selectin and ICAM-1 (Figure 3B). Similarly, blocking
mitogen-activated protein (MAP)-kinase p38 did not influ-
ence the rolling velocity on E-selectin (data not shown) but
partially elevated the rolling velocity on E-selectin and
ICAM-1 (Figure 3C).
TNF-a, but Not IL-1b, Induces Neutrophil
Adhesion under Flow
In many in vivo models, inflammation is induced by inject-
ing TNF-a, which causes upregulation of adhesion mole-
cules on endothelial cells, slow rolling, adhesion, and
recruitment of leukocytes (Kunkel et al., 2000). Pretreat-
ment of WT mice with TNF-a did not change the rolling
velocity in autoperfused flow chambers coated with E-
selectin. After TNF-a, but not IL-1b, the rolling velocity
on E-selectin and ICAM-1 dropped further (Figure 4A).
TNF-a, but not interleukin-1b (IL-1b), treatment also in-
duced neutrophil adhesion on E-selectin and ICAM-1
(Figure 4B). Adhesion was induced by TNF-a-treated,Figure 2. Continuous E-Selectin En-
gagement Is Required to Keep LFA-1 in
an Activated Conformation
(A) The first half of autoperfused flow cham-
bers was coated with E-selectin+ICAM-1 and
the second half with ICAM-1 alone, border
indicated by vertical line. Cells rolled on
E-selectin+ICAM-1 but detached immediately
upon reaching ICAM-1 alone (representative
of four independent experiments).
(B) Number of rolling neutrophils on E-selectin+
ICAM-1-coated chambers before and after
injection of a blocking E-selectin antibody
(9A9). Data presented are the mean ± SEM
from at least four mice and four flow chambers
(n = 4). #p < 0.05.
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Spleen Tyrosine Kinase Necessary for Slow RollingFigure 3. Syk Is Involved in Integrin Activation after E-Selectin or P-Selectin Binding to PSGL-1
Whole blood was perfused through E-selectin- and E-selectin+ICAM-1-coated autoperfused flow chambers at 5.94 dyn/cm2.
(A and B) The rolling velocity of neutrophils from mice pretreated with piceatannol (1 mg/mouse, [A]), a specific Syk inhibitor, and Syk/ chimeric
mice (B) were determined after 6 min (n = 4).
(C) Rolling velocity on E-selectin and E-selectin+ICAM-1 was measured after blocking of the mitogen-activated protein (MAP)-kinase p38 by the
inhibitor SB203580 (100 mg/mouse i.p.) 1 hr prior to the experiment (n = 3).
#p < 0.05. Data presented are mean ± SEM.but not IL-1b-treated, blood, showing that factors pro-
duced by blood cells are sufficient for this effect
(Figure 4C). To test whether chemokine deposition on
the surface of E-selectin- and ICAM-1-coated flow cham-
bers during the perfusion of whole blood through the
chamber was relevant, we perfused E-selectin- and
ICAM-1-coated flow chambers with plasma from un-
treated or TNF-a-treated mice for 6 min. Then, these
same flow chambers were connected to untreated mice.
Perfusion of plasma from TNF-a-treated mice did not in-
duce neutrophil adhesion (Figure S1 in the Supplemental
Data available online).
In order to investigate which conformation of LFA-1 is
responsible for slow rolling and adhesion, we used an al-
losteric inhibitor of LFA-1 (Compound 6845). This inhibitor
is a structural analog of the allosteric inhibitor XVA143
(Shimaoka et al., 2003a), which has been shown to target
the I-like domain on the b2-subunit and prevent firm adhe-
sion by stabilizing the aLb2 heterodimer, activating the b2
I-like domain, and inhibiting activation of the a I domain.
This inhibitor therefore stabilizes the intermediate affinity
conformation of LFA-1. Pretreatment of mice with the allo-
steric inhibitor before TNF-a application did not influence
the rolling velocity on E-selectin and E-selectin and ICAM-
1 compared to vehicle-treated mice (Figure 4D), but abol-
ished leukocyte adhesion in response to TNF-a (Figure 4E).
These data show that intermediate-affinity LFA-1 is re-
sponsible for slow rolling, whereas the fully activated
conformation with high affinity of LFA-1 is necessary for
leukocyte adhesion to ICAM-1.
CXCR2, but Not Syk, Controls Neutrophil Arrest
in Response to TNF-a
CXCR2 is an important chemokine receptor for neutrophil
adhesion (Smith et al., 2004a). In order to investigatewhether GPCRs and specifically CXCR2 is involved in
the modulation of rolling velocities and to address whether
Syk is downstream of CXCR2, we used PTx to inhibit Gai,
piceatannol to inhibit Syk, and Syk/ chimeric mice. PTx
and piceatannol did not influence the rolling velocity on
E-selectin (Figure 5A). Syk inhibition by piceatannol com-
pletely prevented the drop of rolling velocity on E-selectin
and ICAM-1, whereas blocking of Gai increased the rolling
velocity by only 28% (Figure 5A). In contrast, PTx totally
abolished neutrophil adhesion, whereas inhibition of Syk
by piceatannol had no effect (Figure 5B).
In order to identify the GPCR involved in neutrophil
adhesion, we used a blocking CXCR2 antibody. Blocking
CXCR2 alone or in combination with Syk did not alter the
rolling velocity on E-selectin. On E-selectin and ICAM-1,
blocking CXCR2 had no effect on rolling velocity, but inhi-
bition of Syk by piceatannol elevated the rolling velocity to
the level seen on E-selectin (Figure 5C). TNF-a-induced
adhesion was completely blocked by the CXCR2 antibody
(Figure 5D). These findings were confirmed by intravital
microscopy of mouse cremaster venules (Figure S2).
Taken together, these results demonstrate that Syk is
not involved in CXCR2-dependent arrest.
To investigate the mechanism by which TNF-a triggered
CXCR2-dependent neutrophil arrest, we investigated
CXCL1 production in neutrophils after TNF-a application
in vivo. We stained the cremaster muscle for CXCL1 (Fig-
ures 5E and 5F) and measured the CXCL1 concentration
in the plasma in the presence or absence of TNF-a (Fig-
ure 5G). Intrascrotal injection of TNF-a 2 hr before exteri-
orization induced an increase of adherent leukocytes
and CXCL1 expression (Figure 5F) in venules of the cre-
master muscle in WT mice compared to untreated mice
(Figure 5E) and increased CXCL1 in plasma (Figure 5G).
Taken together with the data presented above, weImmunity 26, 773–783, June 2007 ª2007 Elsevier Inc. 777
Immunity
Spleen Tyrosine Kinase Necessary for Slow RollingFigure 4. TNF-a, but Not IL-1b, Causes Neutrophil Arrest on E-Selectin + ICAM-1
(A) Carotid cannulas of TNF-a- or IL-1b-pretreated mice were connected to E-selectin- and E-selectin+ICAM-1-coated autoperfused flow chambers.
Rolling velocity of neutrophils was determined at a wall shear stress of 5.94 dyn/cm2 (n = 4).
(B and C) Number of adherent neutrophils on E-selectin+ICAM-1 of TNF-a-pretreated mice (B) or TNF-a-pretreated whole blood (C) after 6 min.
(D and E) Mice were pretreated with TNF-a and an allosteric inhibitor (Compound 6845) of LFA-1 or vehicle, and rolling velocity (D) and number of
adherent neutrophils (E) were determined on E-selectin and E-selectin+ICAM-1. To ensure that only LFA-1-dependent rolling and adhesion were
investigated, all mice were treated with a blocking monoclonal antibody to Mac-1 (n = 4).
*p < 0.05; #p < 0.05. Data presented are mean ± SEM.conclude that TNF-a induced CXCL1 activates LFA-1
through CXCR2 and Gai to promote arrest, whereas liga-
tion of PSGL-1 by E-selectin induces partial LFA-1 activa-
tion through Syk to promote slow rolling on E-selectin and
ICAM-1 (Figure S3).
Inhibitions of Syk and GPCR Signaling Reduce
Neutrophil Recruitment
The inability of neutrophils from PSGL-1-deficient mice to
roll on ICAM-1 upon E-selectin engagement and the elim-
ination of adhesion by blocking CXCR2 after TNF-a appli-
cation suggests that inhibition of both PSGL-1 signaling
and chemokine-mediated adhesion may prevent neutro-
phil influx into inflamed tissues. To compare the physiolog-
ical importance of the two signaling pathways, neutrophil
recruitment into thioglycollate-induced peritonitis was in-
vestigated in WT,Selplg/, andSele/mice with or with-
out PTx treatment. Consistent with previous data (Smith
et al., 2004a), pretreatment with PTx reduced neutrophil
recruitment to the peritoneum 4 hr after thioglycollate
injection into WT mice (Figure 6). Selplg/ mice also
showed a reduced neutrophil influx after thioglycollate ap-778 Immunity 26, 773–783, June 2007 ª2007 Elsevier Inc.plication compared to WT mice (Yang et al., 1999). How-
ever, blocking both pathways by combining PTx treatment
with the absence of PSGL-1 almost completely eliminated
neutrophil recruitment into the peritoneal cavity after thio-
glycollate injection (Figure 6). In order to show Syk involve-
ment, we used either Syk/ bone-marrow chimeric mice
or blocked Syk by the inhibitor piceatannol (Figure 6).
Blocking of Syk by piceatannol showed no reduction of
neutrophil influx (data not shown), but pharmacological
blockade of Gai in Syk
/ chimeric mice or blockade of
both Gai and Syk in WT mice almost completely abolished
thioglycollate-induced neutrophil recruitment to the peri-
toneal cavity (Figure 6). These data suggest that PSGL-1-
Syk signaling and chemokine-GPCR signaling together
control neutrophil recruitment in this model of thioglycol-
late-induced peritonitis.
DISCUSSION
Many studies have demonstrated that E-selectin engage-
ment leads to activation of neutrophils (Chesnutt et al.,
2006; Green et al., 2004; Mattila et al., 2005; Simon
Immunity
Spleen Tyrosine Kinase Necessary for Slow RollingFigure 5. CXCR2 and Gai, but Not Syk, Control Neutrophil Arrest in Response to TNF-a
(A and B) Rolling velocity (A) and adhesion (B) of neutrophils from TNF-a-pretreated mice on E-selectin- and E-selectin+ICAM-1-coated flow cham-
bers after blocking Gai with PTx or Syk by piceatannol alone or in combination.
(C and D) Rolling velocity (C) and neutrophil adhesion (D) on E-selectin+ICAM-1-coated flow chambers after blockade of CXCR2 by antibody or of Syk
by piceatannol alone or in combination after TNF-a application.
(E and F) Cremaster muscles of WT mice were stained for CXCL1 without (E) and with (F) TNF-a. TNF-a injection induced an increase in adherent
leukocytes in the microcirculation of the cremaster muscle in WT mice compared to untreated mice. Inserts show typical neutrophils stained for
CXCL1 (E, F).
(G) CXCL1 concentration in plasma before and 2 hr after TNF-a injection (n = 4).
#p < 0.05. Data presented are mean ± SEM.et al., 2000), but the ligand responsible for signaling was
unknown. Here, we demonstrate that PSGL-1 is the sig-
naling molecule responsible for LFA-1-dependent rolling
upon E- or P-selectin engagement. This interaction in-
duces Syk-dependent partial LFA-1 activation that causes
slow rolling on ICAM-1, but not arrest. In response to TNF-
a, neutrophils produce CXCL1, which fully activates LFA-1
through CXCR2 and Gai in an autocrine or paracrine man-
ner and causes firm adhesion.
Syk has previously been shown to be responsible for
signaling events (Berton et al., 2005) secondary to out-
side-in signaling through integrins (Mocsai et al., 2002;
Schymeinsky et al., 2006). Syk was needed for respiratory
burst, degranulation, and spreading in response to proin-
flammatory stimuli (Mocsai et al., 2002) but not for G
protein-coupled receptor signaling (Mocsai et al., 2003).
Although Syk was previously shown to be activated by
PSGL-1 (Urzainqui et al., 2002), our experiments with neu-
trophils in their native whole blood suggest that Syk is
involved in the signaling pathway leading to b2-integrin
conformational change upon PSGL-1 binding to E-selec-
tin or P-selectin. Syk-deficient neutrophils or Syk block-ade increased rolling velocities on E-selectin and ICAM-
1 similar to rolling velocities seen on E-selectin alone.
We confirm that Syk is not involved in the signaling down-
stream of CXCR2 (Mocsai et al., 2003). Inhibition of Syk
did not reduce the number of adherent neutrophils upon
TNF-a stimulation, and Syk chimeric mice showed a simi-
lar increase in leukocyte arrest upon CXCL1 application.
Also, blocking Syk had no effect on rolling on E-selectin,
suggesting that Syk blockade does not introduce gross
morphological changes such as flattening of microvilli.
It has long been known that E-selectin induces slow roll-
ing (Kunkel and Ley, 1996; Ley et al., 1998; Norman et al.,
2000). This slow rolling also requires CD18 integrins
(Dunne et al., 2002, 2003; Jung et al., 1998; Kunkel et al.,
2000), but the mechanism of integrin activation was not
understood. Our in vivo and in vitro data show that the
b2-integrin LFA-1, and not Mac-1, is responsible for
E-selectin-induced slow rolling. Depending on the state
of activation, integrins can be found in different conforma-
tions with different affinities to their ligands (Shimaoka
et al., 2003b). The b2-integrin LFA-1 in the intermediate-
affinity conformation mediates rolling on ICAM-1, whereasImmunity 26, 773–783, June 2007 ª2007 Elsevier Inc. 779
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duces arrest (Salas et al., 2004; Shimaoka et al., 2003b).
An allosteric LFA-1 inhibitor that stabilizes the intermediate
conformation did not influence slow rolling, suggesting
that PSGL-1 binding to E-selectin induces the intermedi-
ate-affinity conformation of LFA-1. An alternative interpre-
tation of our data is that some fraction of LFA-1 exists in the
partially open, intermediate-affinity state, and that Syk is
involved in outside-in signaling after ligand engagement,
which may stabilize this conformation. By contrast, the
chemokine-induced adhesion after TNF-a application
was completely blocked by this allosteric inhibitor, sug-
gesting that firm adhesion requires the high-affinity confor-
mation of LFA-1.
The discovery of partial LFA-1 activation by PSGL-1
engagement was made possible by using neutrophils in
whole blood rather than isolated neutrophils. Isolated neu-
trophils express increased levels of Mac-1 and show a de-
creased ability to roll (Forsyth and Levinsky, 1990; Glasser
and Fiederlein, 1990; Kuijpers et al., 1991). As a case in
point, isolated human neutrophils rolled at similar veloci-
ties on L-cells transfected with E-selectin alone or in com-
bination with ICAM-1 (Simon et al., 2000), whereas we
show a clear difference in rolling velocity on E-selectin ver-
sus E-selectin and ICAM-1. PSGL-1 engagement by E-se-
lectin leads to slow rolling by inducing the partially acti-
vated conformation of LFA-1. This was probably missed
in earlier studies, because isolated neutrophils are already
partially activated.
TNF-a primes neutrophils and induces increased sur-
face expression of CD11b, oxidative burst (Nathan et al.,
1989; Richter et al., 1995), and chemokine production (Ha-
Figure 6. Inhibition of Gai in Selplg
/ Mice Blocks Neutrophil
Recruitment In Vivo
Peritoneal neutrophil influx 4 hr after 1 ml injection of 4% thioglycollate
into WT mice, WT mice that had received 4 mg PTx before thioglycol-
late injection, Selplg/ mice, Selplg/ mice plus PTx, Sele/ mice
plus PTx, WT mice that had received 1 mg piceatannol (picea) and
4 mg PTx, and Syk/ chimeric mice (Syk/) plus 4 mg PTx (n = 5
each). Data expressed as total numbers of neutrophils in the peritoneal
lavage fluid counted by means of Kimura-stained samples, #p < 0.05.780 Immunity 26, 773–783, June 2007 ª2007 Elsevier Inc.chicha et al., 1995). Here we show that TNF-a also triggers
neutrophil adhesion on E-selectin and ICAM-1 through
CXCR2 and Gai. Blocking of Gai-coupled receptors by
PTx abolished neutrophil adhesion and also influenced
rolling velocity. Antibody blockade of CXCR2 prevented
neutrophil adhesion but did not influence the rolling veloc-
ity. These data demonstrate that CXCR2 is an important
receptor for adhesion and suggest that other Gai-coupled
receptors may be involved in controlling rolling velocity.
After TNF-a application, CXCL1 production in neutro-
phils and systemic CXCL1 concentrations increased.
The treatment of isolated blood with TNF-a demonstrates
that CXCL1 produced in neutrophils (Hachicha et al.,
1995) activates CXCR2 in an autocrine or paracrine way
and effectively induces arrest. Taken together, our results
show that different signaling pathways for slow LFA-1-de-
pendent rolling and arrest exist, but this study does not
address where the Gai- and Syk-signaling pathways con-
verge. Downstream molecules that have been implicated
in integrin activation include p38 MAPK (Simon et al.,
2000), ERM proteins (Urzainqui et al., 2002), and talin
(Tadokoro et al., 2003).
Previous work has shown reduced neutrophil recruit-
ment to thioglycollate-induced peritonitis in Selplg/
mice (Yang et al., 1999) and in PTx-treated mice (Smith
et al., 2004a). Treating Sele/ mice with PTx almost com-
pletely abolished neutrophil recruitment in this model
(Smith et al., 2004a). Here, we directly show the relevance
of the PSGL-1 pathway by demonstrating that PTx treat-
ment of Selplg/ mice blocks neutrophil recruitment as
effectively as PTx treatment of Sele/ mice. These data
show that both the PSGL-1-Syk pathway and the
CXCR2-Gai pathway are physiologically relevant in vivo.
Therefore, therapeutic anti-inflammatory strategies tar-
geting neutrophils must consider both chemokine and
E-selectin pathways. Because most lymphocytes bind
E-selectin poorly (Ley and Kansas, 2004), novel anti-in-
flammatory strategies may be able to spare lymphocyte
trafficking and thus avoid unwanted immunosuppression.
EXPERIMENTAL PROCEDURES
Animals and Generation of Bone-Marrow Chimeras
We used 8- to 12-week-old C57BL76 mice (Jackson Laboratory, Bar
Harbor, ME), P-selectin, E-selectin, CD44, and PSGL-1-deficient mice
backcrossed to C57BL/6 for at least 10 generations. Mice carrying the
Syktm1Tyb mutation (Turner et al., 1995) were maintained as Syk+/ het-
erozygotes on the C57BL/6 genetic background. The generation of
mice with a Syk/ hematopoetic system was performed as described
previously (Mocsai et al., 2002). Mice were housed in a barrier facility
under specific pathogen-free conditions. The Animal Care and Use
Committee of the University of Virginia (Charlottesville) approved all
animal experiments.
Antibodies, Cytokines, Recombinant Proteins,
and Other Reagents
Recombinant murine E-selectin-Fc, P-selectin-Fc, ICAM-1-Fc, tumor
necrosis factor (TNF)-a, interleukin (IL)-1b, and the blocking CXCR2
mAb (clone 242216) were obtained from R&D Systems (Minneapolis,
MN). CXCL1 (keratinocyte-derived chemokine [KC]) was purchased
from PeproTech (Rocky Hill, NJ). The Syk-inhibitor piceatannol
Immunity
Spleen Tyrosine Kinase Necessary for Slow Rollingwas purchased from A.G. Scientific (San Diego, CA) and was used in a
concentration of 1 mg per mouse. The blocking mAb 9A9 (rat immuno-
globulin G1 [IgG1], 30 mg per mouse) against murine E-selectin was
provided by B. Wolitzky (MitoKor, San Diego, CA). The blocking lym-
phocyte function antigen (LFA)-1 mAb TIB-217 (rat IgG2a, 30 mg per
mouse) was purified at the biomolecular facility of the University of Vir-
ginia from hybridoma supernatant (ATCC, Rockville, MD). The blocking
Mac-1 mAb M1/70 (rat IgG2b, 30 mg per mouse) was purchased from
Pharmingen (San Diego, CA). The small molecule antagonist, Com-
pound 6845, binds to the b2 subunit I-like domain and was a gift
from G. Ju (Roche, Nutley, NJ). If not stated otherwise, all other re-
agents were obtained from Sigma-Aldrich (Sigma Chemical Co., St.
Louis, MO).
Surgical Preparation and Intravital Microscopy
Mice were anesthetized with an i.p. injection of ketamine hydrochloride
(125 mg/kg, Sanofi Winthrop Pharmaceuticals, New York, NY), atro-
pine sulfate (0.025 mg/kg, Fujisawa USA, Inc., Deerfield, IL), and xyla-
zine (12.5 mg/kg, Tranqui Ved, Phonix Scientific, Inc., St. Joseph, MO)
and placed on a heating pad to maintain the body temperature at 37C.
After tracheal intubation (Polyethylene PE 90 tubing, ID 0.86 mm, OD
1.27 mm), cannulation of the carotid artery (PE 10, ID 0.28 mm, OD
0.61 mm) and flushing the cannula with 10 units heparin sodium per
ml saline, the cremaster muscle was prepared for intravital microscopy
as previously described (Ley et al., 1995). Microscopic observations
were conducted on postcapillary venules ranging from 20 to 40 mm
in diameter with an intravital microscope (Axioskop; Zeiss, Thorn-
wood, NY) with a saline immersion objective (SW 40, 0.75 numerical
aperture). A CCD camera (model VE-1000CD, Dage-MTI) was used
for recording. Surface area, S, was calculated for each vessel by
S = p*d*ln, where d is the diameter and ln is the length of the vessel.
Rolling flux was measured as the number of cells that roll past a line
perpendicular to the vessel axis per minute. Leukocyte rolling flux frac-
tion is defined as the flux of rolling leukocytes in percent of total leuko-
cyte flux (Ley and Gaehtgens, 1991). Leukocyte arrest was determined
before and 1 min after intravenous injection of 600 ng CXCL1 as
described previously (Smith et al., 2004a). Arrest was defined as leuko-
cyte adhesion longer than 30 s and expressed as cells per surface
area. Blood-flow centerline velocity was measured with dual photodi-
ode and a digital online cross-correlation program (Circusoft Instru-
mentation, Hockessin, DE). Centerline velocities were converted to
mean blood-flow velocities by multiplying with an empirical factor of
0.625 (Lipowsky and Zweifach, 1978).
Blood-Perfused Microflow Chamber
In order to investigate the rolling velocity, the number of rolling cells,
and adherent cells, we used a recently described microflow chamber
system (Chesnutt et al., 2006; Smith et al., 2006). 203 200 mm rectan-
gular glass capillaries were filled with E-selectin (30 mg/ml) or P-selec-
tin (20 mg/ml) alone or in combination with ICAM-1 (15 mg/ml) and/or
CXCL1 (10 mg/ml) for 2 hr and blocked for 1 hr with 10% casein (Pierce
Chemicals, Dallas, TX). The chamber was connected at one side to a
PE 10 tubing and inserted into the carotid artery. The other side of
the chamber was connected to a PE 50 tubing and used to control
the wall shear stress, which was calculated as described (Smith
et al., 2004b). Microscopy was conducted with a Zeiss Axioskop
(Carl Zeiss, Inc., Thornwood, NY) with a saline immersion objective
(SW 20, N.A. 0.5). Images were recorded with a 3CCD color video cam-
era (model DXC-390, SONY Corporation, Japan) connected to a Pana-
sonic S-VHS recorder. The chamber was perfused with blood for 6 min
before one representative field of view was recorded for 1 min.
In some experiments, blood was collected by cardiac puncture and
stimulated with IL-1b (10 ng/ml) or TNF-a (10 ng/ml) for 30 min accord-
ing to a previously published protocol (Thompson et al., 2001).
Chemokines
CXCL1 (keratinocyte-derived chemokine [KC]) concentration in
plasma was measured in triplicates by enzyme-linked immunosorbentassay kits according to the manufacturer’s instructions (R&D Systems,
Minneapolis, MN) under baseline conditions and 2 hr after TNF-a injec-
tion. Paraffin-embedded cremaster sections (5 mm) were incubated
with a goat anti-mouse polyclonal antibody against KC (C-19, Santa
Cruz Biotechnology, Santa Cruz, CA). This was followed by a biotiny-
lated secondary antibody (Vector Laboratories, CA) and avidin-biotin-
peroxidase (Vector Laboratories). Sections stained without primary
antibody served as negative controls.
Pertonitis Model
Peritoneal recruitment of leukocytes was induced as previously de-
scribed (Smith et al., 2004a). In brief, 1 ml of sterile water containing
4% thioglycollate was injected i.p. 4 hr before the peritoneal lavage
with 10 ml PBS (containing 2 mM EDTA) was performed. Total number
of neutrophils was determined by Kimura staining. Some mice received
tail-vein injections of 4 mg PTx 2 hr before thioglycollate injection.
Statistics
Statistical analysis was performed with SPSS (version 14.0, Chicago,
IL) and included one-way analysis of variance, Student-Newman-
Keuls test, and t test where appropriate. All data are presented as
mean ± SEM. p < 0.05 were considered significant.
Supplemental Data
Three figures are available at http://www.immunity.com/cgi/content/
full/26/6/773/DC1/.
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Note Added in Proof
While this manuscript was in press, Frenette and colleagues reported
on E-selectin ligands in neutrophils (Hidalgo, A., Peired, A.J., Wild,
M.K., Vestweber, D., and Frenette, P.S. (2007). Complete identification
of E-selectin ligands on neutrophils reveals distinct functions of PSGL-
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